By phase — BA-BE through IV
From bioequivalence studies and first-in-human dose escalation to post-marketing surveillance. The same schema carries the study through every phase.
BA-BE: pre-built templates, replicate-design support, intensive PK sampling.
Phase II/III: multi-site scale, edit checks at entry, and your RBQM tools connected.
Phase IV: long-running follow-up at scale, low-friction site burden.
- 30 minutesTo see it running on your own protocolNo scoping call, no quote and no purchase order first.
- 10 minutesTo stand a study build up end to endThe eCRF itself is instant — the AI Designer drafts it from your protocol.
- No codeTo build your forms, checks and visit scheduleDoing it by hand takes most teams 4–8 weeks.
- OneData model behind every moduleEnter data once and it is everywhere. Nothing to match up later.
- ZeroExtra fees per form, per query or per exportThe price is the same whether you collect 10 records or 10,000.
Other ways teams use Trialion
Bioequivalence (BA-BE) specialists
Replicate designs and intensive PK sampling, without a second system. Pre-built templates, volunteer randomization tied to dispensing, and ANDA-ready exports from the same data model.
Learn moreGeneric-drug CROs
Short, focused trials, run at volume. Repeat protocol designs set up in days, priced per study or per month, with the whole portfolio on one data model.
Learn moreMulti-therapy CROs
Phase II to IV across therapeutic areas, on one data model. Configurable workflows and a single continuous audit trail, whatever the indication.
Learn more